GMT Capital’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

GMT Capital’s Portfolio YTEN Stock Details YTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-35	Closed	-$17K	–	82
2019 Q3	$17K	Hold	35	–	–	﹤0.01%	88
2019 Q2	$33K	Buy	+35	New	+$33.5K	﹤0.01%	83
2019 Q1	–	Sell	-32	Closed	-$26K	–	89
2018 Q4	$26K	Sell	32 -3	-9%	-$3.66K	﹤0.01%	72
2018 Q3	$48K	Hold	35	–	–	﹤0.01%	103
2018 Q2	$47K	Hold	35	–	–	﹤0.01%	110
2018 Q1	$65K	Buy	+35	New	+$59.3K	﹤0.01%	98
2017 Q4	–	Sell	-35	Closed	-$107K	–	139
2017 Q3	$107K	Buy	+35	New	+$98.3K	﹤0.01%	139
2017 Q1	–	Sell	-33	Closed	-$110K	–	144
2016 Q4	$110K	Sell	33 -2	-6%	-$7.68K	﹤0.01%	130
2016 Q3	$151K	Hold	35	–	–	﹤0.01%	134
2016 Q2	$279K	Buy	+35	New	+$395K	0.01%	122
2016 Q1	–	Sell	-12	Closed	-$183K	–	138
2015 Q4	$183K	Sell	12 -27	-69%	-$544K	﹤0.01%	101
2015 Q3	$775K	Hold	39	–	–	0.02%	108
2015 Q2	$1.39M	Buy	39 +33	+550%	+$1.36M	0.04%	92
2015 Q1	$227K	Buy	+6	New	+$192K	0.01%	97
2013 Q4	–	Sell	-4	Closed	-$255K	–	93
2013 Q3	$255K	Hold	4	–	–	0.01%	98
2013 Q2	$287K	Buy	+4	New	+$387K	0.01%	99

Other funds holding YTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

GMT Capital's YTEN Position: Q4 2019 in Review

GMT Capital sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q4 2019, closing a stake of 35 shares — an estimated $17K sold.

GMT Capital first reported a position in YTEN in Q2 2013 and held it in 16 quarters. The position peaked at $1.39M in Q2 2015. 10 funds tracked by Wall St. Rank hold YTEN as of Q4 2019.

GMT Capital reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
GMT Capital sold 35 Yield10 Bioscience, Inc. Common Stock shares in Q4 2019, an estimated $17K.
GMT Capital first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2013 and held it in 16 quarters.
GMT Capital's Yield10 Bioscience, Inc. Common Stock position peaked at $1.39M in Q2 2015.
10 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q4 2019.

Based on GMT Capital's 13F filing for Q4 2019, filed 14 Feb 2020.